$FNCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Lev Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Lev Pharmaceuticals Inc. Get notifications about new insider transactions in Lev Pharmaceuticals Inc for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Option Exercise | X | 1.66 | 900,000 | 1,491,840 | 0 | |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Sell | U | 2.75 | 17,582,700 | 48,352,425 | 0 | 17.6 M to 0 (-100.00 %) |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | X | 1.66 | 900,000 | 1,491,840 | 17,582,700 | 16.7 M to 17.6 M (+5.39 %) |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Option Exercise | X | 1.66 | 900,000 | 1,491,840 | 0 | |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Sell | U | 2.75 | 17,642,700 | 48,517,425 | 0 | 17.6 M to 0 (-100.00 %) |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | X | 1.66 | 900,000 | 1,491,840 | 17,642,700 | 16.7 M to 17.6 M (+5.38 %) |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Option Exercise | X | 1.66 | 900,000 | 1,491,840 | 0 | |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Sell | U | 2.75 | 17,542,700 | 48,242,425 | 0 | 17.5 M to 0 (-100.00 %) |
| Mar 20 2009 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | X | 1.66 | 900,000 | 1,491,840 | 17,542,700 | 16.6 M to 17.5 M (+5.41 %) |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | EAGLE SCOTT | Director | Option Exercise | D | 1.63 | 75,000 | 122,250 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | EAGLE SCOTT | Director | Option Exercise | D | 0.80 | 225,000 | 180,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | Dachowitz Henry | Director | Option Exercise | D | 1.94 | 100,000 | 194,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chief Executive Off ... | Option Exercise | D | 1.60 | 1,600,000 | 2,560,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chief Executive Off ... | Option Exercise | D | 0.30 | 1,427,450 | 428,235 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chief Executive Off ... | Sell | D | 2.75 | 500,735 | 1,377,021 | 0 | 500.7 K to 0 (-100.00 %) |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chief Executive Off ... | Sell | D | 2.75 | 15,003,968 | 41,260,912 | 0 | 15 M to 0 (-100.00 %) |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | BECK DOUGLAS | Chief Financial Off ... | Option Exercise | D | 0.50 | 125,000 | 62,500 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | BECK DOUGLAS | Chief Financial Off ... | Option Exercise | D | 1.20 | 100,000 | 120,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | RICHMAN ERIC I | Director | Option Exercise | D | 1.63 | 75,000 | 122,250 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | RICHMAN ERIC I | Director | Option Exercise | D | 1.63 | 75,000 | 122,250 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | RICHMAN ERIC I | Director | Option Exercise | D | 0.80 | 225,000 | 180,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | LANIER THOMAS | Director | Option Exercise | D | 1.63 | 75,000 | 122,250 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | LANIER THOMAS | Director | Option Exercise | D | 0.80 | 225,000 | 180,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | LANIER THOMAS | Director | Sell | D | 2.75 | 71,372 | 196,273 | 0 | 71.4 K to 0 (-100.00 %) |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Option Exercise | D | 1.60 | 1,600,000 | 2,560,000 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Option Exercise | D | 0.30 | 1,427,450 | 428,235 | 0 | |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Sell | D | 2.75 | 14,838,214 | 40,805,089 | 0 | 14.8 M to 0 (-100.00 %) |
| Oct 02 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 2.10 | 556,200 | 1,167,019 | 17,642,700 | 17.1 M to 17.6 M (+3.26 %) |
| Oct 21 2008 | FNCY | Lev Pharmaceutical ... | Elefant Dov | Corporate Controlle ... | Option Exercise | D | 1.75 | 200,000 | 350,000 | 0 | |
| Oct 02 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 2.10 | 556,200 | 1,167,019 | 17,542,700 | 17 M to 17.5 M (+3.27 %) |
| Oct 02 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 2.10 | 556,200 | 1,167,019 | 17,582,700 | 17 M to 17.6 M (+3.27 %) |
| Aug 26 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Gift | G | 0.00 | 1,900,000 | 0 | 14,838,214 | 16.7 M to 14.8 M (-11.35 %) |
| Aug 26 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Gift | G | 0.00 | 525,000 | 0 | 15,002,968 | 15.5 M to 15 M (-3.38 %) |
| May 05 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Gift | G | 0.00 | 129,740 | 0 | 0 | 129.7 K to 0 (-100.00 %) |
| May 05 2008 | FNCY | Lev Pharmaceutical ... | PRISM VENTURES LLC | 10% Owner | Sell | J | 0.00 | 6,851,759 | 0 | 0 | 6.9 M to 0 (-100.00 %) |
| May 05 2008 | FNCY | Lev Pharmaceutical ... | PRISM VENTURES LLC | 10% Owner | Sell | J | 0.00 | 20,311,918 | 0 | 0 | 20.3 M to 0 (-100.00 %) |
| May 05 2008 | FNCY | Lev Pharmaceutical ... | PRISM VENTURES LLC | 10% Owner | Gift | G | 0.00 | 129,740 | 0 | 20,311,918 | 20.4 M to 20.3 M (-0.63 %) |
| May 05 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Gift | G | 0.00 | 129,740 | 0 | 500,735 | 630.5 K to 500.7 K (-20.58 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.88 | 56,000 | 49,280 | 17,086,500 | 17 M to 17.1 M (+0.33 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.90 | 112 | 101 | 17,030,500 | 17 M to 17 M (0.00 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.87 | 2,688 | 2,339 | 17,030,388 | 17 M to 17 M (+0.02 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.86 | 6,700 | 5,762 | 17,027,700 | 17 M to 17 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 17,021,000 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 17,018,500 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 17,016,000 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 17,013,500 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.85 | 7,500 | 6,375 | 17,011,000 | 17 M to 17 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.90 | 2,500 | 2,250 | 17,003,500 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.90 | 1,000 | 900 | 17,001,000 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.88 | 56,000 | 49,280 | 17,026,500 | 17 M to 17 M (+0.33 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.90 | 112 | 101 | 16,970,500 | 17 M to 17 M (0.00 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.87 | 2,688 | 2,339 | 16,970,388 | 17 M to 17 M (+0.02 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.86 | 6,700 | 5,762 | 16,967,700 | 17 M to 17 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,961,000 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,958,500 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,956,000 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,953,500 | 17 M to 17 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.85 | 7,500 | 6,375 | 16,951,000 | 16.9 M to 17 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.90 | 2,500 | 2,250 | 16,943,500 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.90 | 1,000 | 900 | 16,941,000 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.88 | 56,000 | 49,280 | 16,986,500 | 16.9 M to 17 M (+0.33 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.90 | 112 | 101 | 16,930,500 | 16.9 M to 16.9 M (0.00 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.87 | 2,688 | 2,339 | 16,930,388 | 16.9 M to 16.9 M (+0.02 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.86 | 6,700 | 5,762 | 16,927,700 | 16.9 M to 16.9 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,921,000 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,918,500 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,916,000 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.85 | 2,500 | 2,125 | 16,913,500 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.85 | 7,500 | 6,375 | 16,911,000 | 16.9 M to 16.9 M (+0.04 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.90 | 2,500 | 2,250 | 16,903,500 | 16.9 M to 16.9 M (+0.01 %) |
| Apr 01 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.90 | 1,000 | 900 | 16,901,000 | 16.9 M to 16.9 M (+0.01 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.79 | 156,600 | 123,714 | 16,900,000 | 16.7 M to 16.9 M (+0.94 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.79 | 50,000 | 39,500 | 16,743,400 | 16.7 M to 16.7 M (+0.30 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.79 | 25,000 | 19,750 | 16,693,400 | 16.7 M to 16.7 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,668,400 | 16.6 M to 16.7 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Mast Credit Opportunities I Ma ... | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,643,400 | 16.6 M to 16.6 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.79 | 156,600 | 123,714 | 16,940,000 | 16.8 M to 16.9 M (+0.93 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.79 | 50,000 | 39,500 | 16,783,400 | 16.7 M to 16.8 M (+0.30 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.79 | 25,000 | 19,750 | 16,733,400 | 16.7 M to 16.7 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,708,400 | 16.7 M to 16.7 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Steinberg David J. | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,683,400 | 16.7 M to 16.7 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.79 | 156,600 | 123,714 | 17,000,000 | 16.8 M to 17 M (+0.93 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.79 | 50,000 | 39,500 | 16,843,400 | 16.8 M to 16.8 M (+0.30 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.79 | 25,000 | 19,750 | 16,793,400 | 16.8 M to 16.8 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,768,400 | 16.7 M to 16.8 M (+0.15 %) |
| Mar 20 2008 | FNCY | Lev Pharmaceutical ... | Madison Christopher B | 10% Owner | Buy | P | 0.78 | 25,000 | 19,500 | 16,743,400 | 16.7 M to 16.7 M (+0.15 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Gift | G | 0.00 | 90,000 | 0 | 3,090,505 | 3 M to 3.1 M (+3.00 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Gift | G | 0.00 | 90,000 | 0 | 27,293,417 | 27.4 M to 27.3 M (-0.33 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Gift | G | 0.00 | 90,000 | 0 | 27,383,417 | 27.5 M to 27.4 M (-0.33 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | PRISM VENTURES LLC | 10% Owner | Gift | G | 0.00 | 90,000 | 0 | 20,441,658 | 20.5 M to 20.4 M (-0.44 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | PRISM VENTURES LLC | 10% Owner | Gift | G | 0.00 | 90,000 | 0 | 20,531,658 | 20.6 M to 20.5 M (-0.44 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Gift | G | 0.00 | 30,000 | 0 | 458,235 | 428.2 K to 458.2 K (+7.01 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Gift | G | 0.00 | 90,000 | 0 | 27,293,417 | 27.4 M to 27.3 M (-0.33 %) |
| Jan 03 2008 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Gift | G | 0.00 | 90,000 | 0 | 27,383,417 | 27.5 M to 27.4 M (-0.33 %) |
| Dec 06 2007 | FNCY | Lev Pharmaceutical ... | Southpoint Capital Advisors LP | 10% Owner | Sell | S | 2.10 | 1,000,000 | 2,100,000 | 11,354,192 | 12.4 M to 11.4 M (-8.09 %) |
| Dec 21 2007 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Grant | A | 0.00 | 2,000,000 | 0 | 2,011,000 | 11 K to 2 M (+18,181.82 %) |
| Dec 21 2007 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Grant | A | 0.00 | 2,000,000 | 0 | 3,000,505 | 1 M to 3 M (+199.90 %) |
| Dec 06 2007 | FNCY | Lev Pharmaceutical ... | Emigrant Capital CORP | 10% Owner | Sell | S | 2.10 | 5,000,000 | 10,500,000 | 11,276,116 | 16.3 M to 11.3 M (-30.72 %) |
| Nov 29 2007 | FNCY | Lev Pharmaceutical ... | Dachowitz Henry | Director | Option Exercise | A | 1.94 | 100,000 | 194,000 | 100,000 | |
| Jun 29 2007 | FNCY | Lev Pharmaceutical ... | Emigrant Capital CORP | 10% Owner | Option Exercise | P | 0.84 | 1,430,769 | 1,201,846 | 1,430,769 | |
| Jun 29 2007 | FNCY | Lev Pharmaceutical ... | Emigrant Capital CORP | 10% Owner | Buy | P | 0.62 | 4,769,231 | 2,956,923 | 16,276,116 | 11.5 M to 16.3 M (+41.45 %) |
| Apr 03 2007 | FNCY | Lev Pharmaceutical ... | Southpoint Capital Advisors LP | 10% Owner | Buy | P | 1.80 | 46,500 | 83,700 | 12,354,192 | 12.3 M to 12.4 M (+0.38 %) |
| Mar 20 2007 | FNCY | Lev Pharmaceutical ... | Elefant Dov | Corporate Controlle ... | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
| Feb 16 2007 | FNCY | Lev Pharmaceutical ... | LANIER THOMAS | Director | Option Exercise | A | 1.63 | 75,000 | 122,250 | 75,000 | |
| Feb 16 2007 | FNCY | Lev Pharmaceutical ... | RICHMAN ERIC I | Director | Option Exercise | A | 1.63 | 75,000 | 122,250 | 75,000 | |
| Feb 16 2007 | FNCY | Lev Pharmaceutical ... | RICHMAN ERIC I | Director | Option Exercise | A | 1.63 | 75,000 | 122,250 | 75,000 | |
| Feb 16 2007 | FNCY | Lev Pharmaceutical ... | EAGLE SCOTT | Director | Option Exercise | A | 1.63 | 75,000 | 122,250 | 75,000 | |
| Jan 19 2007 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Option Exercise | A | 1.60 | 1,600,000 | 2,560,000 | 1,600,000 | |
| Jan 19 2007 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman & Executiv ... | Option Exercise | A | 1.60 | 1,600,000 | 2,560,000 | 1,600,000 | |
| Jun 20 2006 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Buy | P | 0.60 | 2,500 | 1,500 | 1,000,505 | 998 K to 1 M (+0.25 %) |
| Jun 19 2006 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Buy | P | 0.57 | 1,000 | 570 | 998,005 | 997 K to 998 K (+0.10 %) |
| Jun 19 2006 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Buy | P | 0.57 | 1,000 | 570 | 997,005 | 996 K to 997 K (+0.10 %) |
| Jun 19 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.57 | 1,000 | 570 | 11,000 | 10 K to 11 K (+10.00 %) |
| Jun 19 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.57 | 1,000 | 570 | 10,000 | 9 K to 10 K (+11.11 %) |
| Jun 15 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.59 | 1,000 | 590 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 15 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.59 | 1,000 | 590 | 1,000 | 0 to 1,000 |
| Jun 13 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.56 | 1,000 | 560 | 7,000 | 6 K to 7 K (+16.67 %) |
| Jun 13 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.53 | 3,500 | 1,855 | 6,000 | 2.5 K to 6 K (+140.00 %) |
| Jun 13 2006 | FNCY | Lev Pharmaceutical ... | COOPER JUDSON A | Chairman and Execut ... | Buy | P | 0.52 | 2,500 | 1,300 | 2,500 | 0 to 2.5 K |
| Jun 14 2006 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Buy | P | 0.59 | 1,500 | 885 | 996,005 | 994.5 K to 996 K (+0.15 %) |
| Jun 14 2006 | FNCY | Lev Pharmaceutical ... | SCHEIN JOSHUA D | Chief Executive Off ... | Buy | P | 0.56 | 1,000 | 560 | 994,505 | 993.5 K to 994.5 K (+0.10 %) |
| Jun 09 2006 | FNCY | Lev Pharmaceutical ... | BECK DOUGLAS | Chief Financial Off ... | Option Exercise | A | 0.50 | 125,000 | 62,500 | 125,000 | |
| Mar 15 2005 | FNCY | Lev Pharmaceutical ... | BECK DOUGLAS | Controller | Option Exercise | A | 1.20 | 100,000 | 120,000 | 100,000 | |
| Dec 08 2004 | FNCY | Lev Pharmaceutical ... | AGRON GARY A | 10% Owner | Buy | J | 0.01 | 871,317 | 8,713 | 1,351,660 | 480.3 K to 1.4 M (+181.39 %) |
| Dec 08 2004 | FNCY | Lev Pharmaceutical ... | Eller James | CEO | Buy | J | 0.01 | 87,131 | 871 | 117,131 | 30 K to 117.1 K (+290.44 %) |
| Dec 08 2004 | FNCY | Lev Pharmaceutical ... | Mathis Family Partners Ltd. | 10% Owner | Sell | J | 0.01 | 87,131 | 871 | 1,234,487 | 1.3 M to 1.2 M (-6.59 %) |
| Dec 08 2004 | FNCY | Lev Pharmaceutical ... | Mathis Family Partners Ltd. | 10% Owner | Buy | J | 0.01 | 871,317 | 8,713 | 1,321,659 | 450.3 K to 1.3 M (+193.48 %) |
| Dec 08 2004 | FNCY | Lev Pharmaceutical ... | MCADAM GARY J | 10% Owner | Buy | J | 0.01 | 871,317 | 8,713 | 1,351,659 | 480.3 K to 1.4 M (+181.40 %) |
Page: 1